Hengrui Medicine (01276): Cyclosporine Eye Drops (IV) Approved by National Drug Administration for Market Launch.

This is a news from the Wise Financial APP. Hengrui Medicine (01276) has announced that its subsidiary, Chengdu Shengdi Pharmaceutical Co., Ltd., recently received a notification from the National Medical Products Administration approving the listing of the company's product, ciclosporin eye drops (IV). This product is the first and only 0.1% anhydrous ciclosporin eye drops in China.